COR
Cencora, Inc.
NYSE: COR · Conshohocken, PA · Healthcare
$279.57+5.49 (+2.00%)Closed
Market Cap$54.39B
Cash$2.18Bmost recent
Runway3 mo$2.31B Q burn
P/E (TTM)35.1EPS $7.96
52-Wk Range$252.16 – $373.25
Avg Volume1.5M3-month
Price & Trading Activity

Daily close with catalyst overlays and trading volume

$279.57+21.1%
Pipeline

Drug candidates sponsored by Cencora · ClinicalTrials.gov

0 drugs · 0 trials
No trials found for this sponsor.
Valuation

Risk-adjusted NPV

Loading pipeline…
Peer comparison

Cohort check

No peer cohort defined for COR. Cohorts currently cover gene editing, mRNA, rare-disease gene therapy, and large-cap biotech — more coming soon.